{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:47:59Z","timestamp":1793908079867,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41423-019-0284-3","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T09:02:41Z","timestamp":1568192561000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system"],"prefix":"10.1038","volume":"18","author":[{"given":"Anil K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamudul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-1675","authenticated-orcid":false,"given":"Madhu M.","family":"Ouseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"284_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrrheum.2014.32","volume":"10","author":"F Rees","year":"2014","unstructured":"Rees, F., Hui, M. & Doherty, M. Optimizing current treatment of gout. Nat. Rev. Rheumatol. 10, 271\u2013283 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"284_CR2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/ard.2009.112508","volume":"68","author":"A So","year":"2009","unstructured":"So, A. & Busso, N. A magic bullet for gout? Ann. Rheum. Dis. 68, 1517\u20131519 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"284_CR3","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"CJ Chen","year":"2006","unstructured":"Chen, C. J. et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116, 2262\u20132271 (2006).","journal-title":"J. Clin. Invest."},{"key":"284_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"284_CR5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI29404","volume":"116","author":"F Martinon","year":"2006","unstructured":"Martinon, F. & Glimcher, L. H. Gout: new insights into an old disease. J. Clin. Invest. 116, 2073\u20132075 (2006).","journal-title":"J. Clin. Invest."},{"key":"284_CR6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrrheum.2009.213","volume":"5","author":"T Bardin","year":"2009","unstructured":"Bardin, T. Acute inflammatory arthritis: interleukin-1 blockade: a magic wand for gout? Nat. Rev. Rheumatol. 5, 594\u2013596 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"284_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/BOR.0000000000000143","volume":"27","author":"A Dumusc","year":"2015","unstructured":"Dumusc, A. & So, A. Interleukin-1 as a therapeutic target in gout. Curr. Opin. Rheumatol. 27, 156\u2013163 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"284_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri3111","volume":"12","author":"X Jiang","year":"2011","unstructured":"Jiang, X. & Chen, Z. J. The role of ubiquitylation in immune defence and pathogen evasion. Nat. Rev. Immunol. 12, 35\u201348 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"284_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrm3394","volume":"13","author":"Y Kulathu","year":"2012","unstructured":"Kulathu, Y. & Komander, D. Atypical ubiquitylation\u2014the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Cell. Mol. Biol. 13, 508\u2013523 (2012).","journal-title":"Nat. Rev. Cell. Mol. Biol."},{"key":"284_CR10","first-page":"1060","volume":"56","author":"S Fechtner","year":"2017","unstructured":"Fechtner, S., Fox, D. A. & Ahmed, S. Transforming growth factor beta activated kinase 1: a potential therapeutic target for rheumatic diseases. Rheumatology 56, 1060\u20131068 (2017).","journal-title":"Rheumatology"},{"key":"284_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nchembio.2211","volume":"13","author":"DS Jones","year":"2017","unstructured":"Jones, D. S. et al. Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation. Nat. Chem. Biol. 13, 38\u201345 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"284_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.39447","volume":"68","author":"AK Singh","year":"2016","unstructured":"Singh, A. K., Umar, S., Riegsecker, S., Chourasia, M. & Ahmed, S. Regulation of transforming growth factor beta-activated kinase activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts: suppression of K(63)-linked autoubiquitination of tumor necrosis factor receptor-associated factor 6. Arthritis Rheum. 68, 347\u2013358 (2016).","journal-title":"Arthritis Rheum."},{"key":"284_CR13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1440-1681.2006.04493.x","volume":"33","author":"M Bruegel","year":"2006","unstructured":"Bruegel, M., Teupser, D., Haffner, I., Mueller, M. & Thiery, J. Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes. Clin. Exp. Pharm. Physiol. 33, 1144\u20131149 (2006).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"284_CR14","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","volume":"186","author":"B Pazar","year":"2011","unstructured":"Pazar, B. et al. Basic calcium phosphate crystals induce monocyte\/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186, 2495\u20132502 (2011).","journal-title":"J. Immunol."},{"key":"284_CR15","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/art.22023","volume":"54","author":"S Ahmed","year":"2006","unstructured":"Ahmed, S., Pakozdi, A. & Koch, A. E. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 54, 2393\u20132401 (2006).","journal-title":"Arthritis Rheum."},{"key":"284_CR16","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1600360","volume":"197","author":"N Akhtar","year":"2016","unstructured":"Akhtar, N., Singh, A. K. & Ahmed, S. MicroRNA-17 suppresses TNF-alpha signaling by interfering with TRAF2 and cIAP2 association in rheumatoid arthritis synovial fibroblasts. J. Immunol. 197, 2219\u20132228 (2016).","journal-title":"J. Immunol."},{"key":"284_CR17","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1073\/pnas.0802675105","volume":"105","author":"S Ahmed","year":"2008","unstructured":"Ahmed, S. et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl Acad. Sci. USA 105, 14692\u201314697 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"284_CR18","doi-asserted-by":"publisher","unstructured":"Singh, A. K., Fechtner, S., Chourasia, M., Sicalo J. & Ahmed S. Critical role of IL-1alpha in IL-1beta-induced inflammatory responses: cooperation with NF-kappaBp65 in transcriptional regulation. FASEB J. https:\/\/doi.org\/10.1096\/fj201801513R (2018).","DOI":"10.1096\/fj201801513R"},{"key":"284_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.taap.2017.05.016","volume":"329","author":"S Fechtner","year":"2017","unstructured":"Fechtner, S., Singh, A., Chourasia, M. & Ahmed, S. Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1beta signaling in rheumatoid arthritis synovial fibroblasts. Toxicol. Appl Pharm. 329, 112\u2013120 (2017).","journal-title":"Toxicol. Appl Pharm."},{"key":"284_CR20","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.4049\/jimmunol.1103426","volume":"188","author":"DC Lacey","year":"2012","unstructured":"Lacey, D. C. et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188, 5752\u20135765 (2012).","journal-title":"J. Immunol."},{"key":"284_CR21","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.38747","volume":"66","author":"LL Reber","year":"2014","unstructured":"Reber, L. L. et al. Contribution of mast cell-derived interleukin-1beta to uric acid crystal-induced acute arthritis in mice. Arthritis Rheum. 66, 2881\u20132891 (2014).","journal-title":"Arthritis Rheum."},{"key":"284_CR22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2019.01027","volume":"10","author":"S Fechtner","year":"2019","unstructured":"Fechtner, S. et al. Cannabinoid receptor 2 agonist JWH-015 inhibits interleukin-1beta-induced inflammation in rheumatoid arthritis synovial fibroblasts and in adjuvant induced arthritis rat via glucocorticoid receptor. Front. Immunol. 10, 1027 (2019).","journal-title":"Front. Immunol."},{"key":"284_CR23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/cb3005897","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-oxozeaenol. ACS Chem. Biol. 8, 643\u2013650 (2013).","journal-title":"ACS Chem. Biol."},{"key":"284_CR24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Crisan","year":"2016","unstructured":"Crisan, T. O. et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann. Rheum. Dis. 75, 755\u2013762 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"284_CR25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molimm.2015.03.250","volume":"66","author":"J Xiao","year":"2015","unstructured":"Xiao, J. et al. Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells. Mol. Immunol. 66, 310\u2013318 (2015).","journal-title":"Mol. Immunol."},{"key":"284_CR26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/18465","volume":"398","author":"J Ninomiya-Tsuji","year":"1999","unstructured":"Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252\u2013256 (1999).","journal-title":"Nature"},{"key":"284_CR27","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1074\/jbc.M609503200","volume":"282","author":"B Lamothe","year":"2007","unstructured":"Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J. Biol. Chem. 282, 4102\u20134112 (2007).","journal-title":"J. Biol. Chem."},{"key":"284_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.rdc.2014.01.013","volume":"40","author":"NL Edwards","year":"2014","unstructured":"Edwards, N. L. & So, A. Emerging therapies for gout. Rheum. Dis. Clin. N. Am. 40, 375\u2013387 (2014).","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"284_CR29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nchembio1207-739","volume":"3","author":"WA Weiss","year":"2007","unstructured":"Weiss, W. A., Taylor, S. S. & Shokat, K. M. Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat. Chem. Biol. 3, 739\u2013744 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"284_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen, T. E. T. & Komander, D. Mechanisms of deubiquitinase specificity and regulation. Annu. Rev. Biochem. 86, 159\u2013192 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"284_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.2012.01108.x","volume":"246","author":"ZJ Chen","year":"2012","unstructured":"Chen, Z. J. Ubiquitination in signaling to and activation of IKK. Immunol. Rev. 246, 95\u2013106 (2012).","journal-title":"Immunol. Rev."},{"key":"284_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","volume":"42","author":"BH Duong","year":"2015","unstructured":"Duong, B. H. et al. A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42, 55\u201367 (2015).","journal-title":"Immunity"},{"key":"284_CR33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/cdd.2017.46","volume":"24","author":"M Lork","year":"2017","unstructured":"Lork, M., Verhelst, K. & Beyaert, R. CYLD, A20 and OTULIN deubiquitinases in NF-kappaB signaling and cell death: so similar, yet so different. Cell Death Differ. 24, 1172\u20131183 (2017).","journal-title":"Cell Death Differ."},{"key":"284_CR34","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.1182364","volume":"327","author":"N Shembade","year":"2010","unstructured":"Shembade, N., Ma, A. & Harhaj, E. W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135\u20131139 (2010).","journal-title":"Science"},{"key":"284_CR35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2011.09.015","volume":"44","author":"B Skaug","year":"2011","unstructured":"Skaug, B. et al. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 44, 559\u2013571 (2011).","journal-title":"Mol. Cell"},{"key":"284_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/art.11486","volume":"50","author":"R Liu","year":"2004","unstructured":"Liu, R., Liote, F., Rose, D. M., Merz, D. & Terkeltaub, R. Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. Arthritis Rheum. 50, 247\u2013258 (2004).","journal-title":"Arthritis Rheum."},{"key":"284_CR37","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","volume":"174","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R., Pritzker, K., Firestein, G. S. & Terkeltaub, R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J. Immunol. 174, 5016\u20135023 (2005).","journal-title":"J. Immunol."},{"key":"284_CR38","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-015-0070-7","volume":"12","author":"SC Zheng","year":"2015","unstructured":"Zheng, S. C. et al. Role of the NLRP3 inflammasome in the transient release of IL-1beta induced by monosodium urate crystals in human fibroblast-like synoviocytes. J. Inflamm. 12, 30 (2015).","journal-title":"J. Inflamm."},{"key":"284_CR39","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.jmedchem.5b01091","volume":"59","author":"AG Baldwin","year":"2016","unstructured":"Baldwin, A. G., Brough, D. & Freeman, S. Inhibiting the inflammasome: a chemical perspective. J. Med. Chem. 59, 1691\u20131710 (2016).","journal-title":"J. Med. Chem."},{"key":"284_CR40","first-page":"2134","volume":"54","author":"G Cavalli","year":"2015","unstructured":"Cavalli, G. & Dinarello, C. A. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology 54, 2134\u20132144 (2015).","journal-title":"Rheumatology"},{"key":"284_CR41","doi-asserted-by":"publisher","unstructured":"Davies K. & Bukhari M. A. S. Recent pharmacological advances in the management of gout. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/kex343 (2017).","DOI":"10.1093\/rheumatology\/kex343"},{"key":"284_CR42","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","volume":"6","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087\u20131095 (2005).","journal-title":"Nat. Immunol."},{"key":"284_CR43","volume":"5","author":"H Cao","year":"2015","unstructured":"Cao, H. et al. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice. Sci. Rep. 5, 14593 (2015).","journal-title":"Sci. Rep."},{"key":"284_CR44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.20132640","volume":"211","author":"Y Xiao","year":"2014","unstructured":"Xiao, Y. et al. TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling. J. Exp. Med. 211, 1689\u20131702 (2014).","journal-title":"J. Exp. Med."},{"key":"284_CR45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jmb.2005.09.098","volume":"354","author":"K Brown","year":"2005","unstructured":"Brown, K. et al. Structural basis for the interaction of TAK1 kinase with its activating protein TAB1. J. Mol. Biol. 354, 1013\u20131020 (2005).","journal-title":"J. Mol. Biol."},{"key":"284_CR46","doi-asserted-by":"crossref","first-page":"33416","DOI":"10.18632\/oncotarget.26058","volume":"9","author":"JW Singer","year":"2018","unstructured":"Singer, J. W. et al. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy. Oncotarget 9, 33416\u201333439 (2018).","journal-title":"Oncotarget"},{"key":"284_CR47","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.1203268","volume":"191","author":"E Pauls","year":"2013","unstructured":"Pauls, E. et al. Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice. J. Immunol. 191, 2717\u20132730 (2013).","journal-title":"J. Immunol."},{"key":"284_CR48","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1073\/pnas.1620139114","volume":"114","author":"E Della Mina","year":"2017","unstructured":"Della Mina, E. et al. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts. Proc. Natl Acad. Sci. USA 114, E514\u2013E523 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0284-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0284-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0284-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:23Z","timestamp":1684617743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-019-0284-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1038\/s41423-019-0284-3","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}